Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Lantheus (LNTH)

Lantheus Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LNTH
DateTimeSourceHeadlineSymbolCompany
13/01/202505:05GlobeNewswire Inc.Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic MarketNASDAQ:LNTHLantheus Holdings Inc
23/12/202421:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
19/12/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
20/11/202411:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
20/11/202406:00GlobeNewswire Inc.Lantheus Announces Share Repurchase ProgramNASDAQ:LNTHLantheus Holdings Inc
19/11/202421:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
18/11/202422:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
15/11/202416:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
14/11/202415:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
13/11/202413:30GlobeNewswire Inc.Lantheus to Present at the Jefferies London Healthcare ConferenceNASDAQ:LNTHLantheus Holdings Inc
12/11/202422:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
11/11/202412:39GlobeNewswire Inc.Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025NASDAQ:LNTHLantheus Holdings Inc
08/11/202421:38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
06/11/202412:42Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LNTHLantheus Holdings Inc
06/11/202412:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
06/11/202412:00GlobeNewswire Inc.Lantheus Reports Third Quarter 2024 Financial ResultsNASDAQ:LNTHLantheus Holdings Inc
04/11/202412:30GlobeNewswire Inc.Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and CareNASDAQ:LNTHLantheus Holdings Inc
23/10/202412:30GlobeNewswire Inc.Lantheus to Host Third Quarter 2024 Earnings Conference Call and Webcast on November 6, 2024, at 8:00 a.m. Eastern TimeNASDAQ:LNTHLantheus Holdings Inc
15/10/202412:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
25/09/202420:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
15/09/202412:45GlobeNewswire Inc.Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024NASDAQ:LNTHLantheus Holdings Inc
13/09/202417:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
05/09/202412:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
05/09/202412:30GlobeNewswire Inc.Lantheus Appoints Julie Eastland as New Board MemberNASDAQ:LNTHLantheus Holdings Inc
03/09/202420:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
28/08/202412:30GlobeNewswire Inc.Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:LNTHLantheus Holdings Inc
21/08/202420:35Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LNTHLantheus Holdings Inc
20/08/202412:30GlobeNewswire Inc.Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024NASDAQ:LNTHLantheus Holdings Inc
19/08/202420:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
16/08/202420:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:LNTH